Isolated cardiac valve involvement in smoldering adult T-cell leukemia/lymphoma

被引:2
作者
Aguilar, Cristian [1 ]
Beltran, Brady E. [2 ,3 ]
Morales, Domingo [4 ,5 ]
Gutierrez-Garibay, Marco [6 ]
Villela, Luis [7 ]
Marques-Piubelli, Mario L. [8 ]
Vega, Francisco [9 ]
Miranda, Roberto N. [9 ]
Malpica, Luis [10 ]
机构
[1] Inst Nacl Cardiovasc, Lab Patol, Coronel Zegarra 417, Lima 15072, Peru
[2] Hosp Edgardo Rebagliati Martins, Dept Oncol, Lima, Peru
[3] Univ San Martin de Porres, Ctr Med Precis, Lima, Peru
[4] Univ Peruana Ciencias Aplicadas, Fac Ciencias Salud, Lima, Peru
[5] Hosp Nacl Hipolito Unanue, Dept Patol, Lima, Peru
[6] Inst Nacl Cardiovasc, Dept Cardiol, Lima, Peru
[7] Hosp Gen Dr Fernando Ocaranza, ISSSTE, Hermosillo, Sonora, Mexico
[8] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA
[9] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
[10] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Lymphoma & Myeloma, Houston, TX 77030 USA
关键词
Adult T -cell leukemia; lymphoma; HTLV-1; cardiac valve; mitral valve; LEUKEMIA-LYMPHOMA; MALIGNANT-LYMPHOMA;
D O I
10.1016/j.carpath.2022.107513
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Adult T-cell leukemia/lymphoma (ATLL) is an aggressive mature T-cell neoplasm caused by infection with the Human T-cell Lymphotropic Virus Type 1 (HTLV-1). Cardiac involvement in patients with ATLL is in-frequent, and when it happens it is usually seen in aggressive ATLL subtypes. However, ATLL presenting as isolated cardiac valve involvement is extremely rare. To date, only three histologically proven cases of ATLL with isolated cardiac valve involvement have been reported. Herein, we describe a 61-year-old Peru-vian man who presented heart failure symptoms secondary to progressive cardiac valve infiltration. The patient underwent mitral valve replacement with a mechanical prosthesis. Histopathological evaluation of the resected valve revealed leaflet thickening with a nodular appearance due to fibrous tissue containing atypical T-lymphocytes with Foxp3 expression, infiltrating all layers of the resected valve. Interestingly, tumor cells were distributed around an incidental venous malformation (i.e., cavernous hemangioma). Postoperative evaluation demonstrated positive serology for HTLV-1, and a diagnosis of ATLL was estab-lished. Postoperative positron emission tomography/computed tomography did not show lesions outside the heart and cell blood counts were within normal range with low level of circulating CD4 + CD25 + lym-phoma cell counts (7%); therefore, patient's disease was considered as smoldering ATLL and a "watch and wait" strategy was pursued. Currently, the patient is alive with no progression of disease after 18 months from diagnosis. Isolated cardiac valve involvement by ATLL should be considered in the differential di-agnosis of HTLV-1 carriers with progressive heart failure, even when systemic lymphoma involvement is absent or not apparent.(c) 2022 Elsevier Inc. All rights reserved.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Heterogeneity in clonal nature in the smoldering subtype of adult T-cell leukemia: continuity from carrier status to smoldering ATL
    Kamihira, Shimeru
    Iwanaga, Masako
    Doi, Yuko
    Sasaki, Daisuke
    Mori, Sayaka
    Tsurda, Kazuto
    Nagai, Kazuhiro
    Uno, Naoki
    Hasegawa, Hiroo
    Yanagihara, Katsunori
    Morinaga, Yoshitomo
    Tsukasaki, Kunihiro
    Taniguchi, Hiroaki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 95 (04) : 399 - 408
  • [42] Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma-Romanian Experience
    Tanase, Alina D.
    Colita, Andrei
    Craciun, Oana G.
    Lipan, Lavinia
    Varady, Zsofia
    Stefan, Laura
    Ranete, Adela
    Pasca, Sergiu
    Bumbea, Horia
    Andreescu, Mihaela
    Popov, Viola
    Bardas, Alexandru
    Coriu, Daniel
    Lupu, Anca Roxana
    Tomuleasa, Ciprian
    Colita, Anca
    Hermine, Olivier
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (08) : 1 - 11
  • [43] Primary B-cell lymphoma of the breast in patient with smoldering type adult T-cell lymphoma
    Ohtsuka, T
    Yamashita, H
    Kuroki, S
    Nakafusa, Y
    Ohta, M
    Shinozaki, K
    Murakami, J
    Chijiiwa, K
    Tanaka, M
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1996, 22 (02): : 197 - 199
  • [44] A Comprehensive Study of the Immunophenotype and its Clinicopathologic Significance in Adult T-Cell Leukemia/Lymphoma
    Tamaki, Tomoko
    Karube, Kennosuke
    Sakihama, Shugo
    Tsuruta, Yuma
    Awazawa, Ryoko
    Hayashi, Masaki
    Nakada, Norihiro
    Matsumoto, Hirofumi
    Yagi, Nobutake
    Ohshiro, Kazuiku
    Nakazato, Iwao
    Kitamura, Sakiko
    Nishi, Yukiko
    Miyagi, Takuya
    Yamaguchi, Sayaka
    Nakachi, Sawako
    Morishimaj, Satoko
    Masuzakij, Hiroaki
    Takahashik, Kenzo
    Fukushimac, Takuya
    Wadaa, Naoki
    MODERN PATHOLOGY, 2023, 36 (08)
  • [45] New treatments for adult T-cell leukemia/lymphoma
    Epstein-Peterson, Zachary D.
    Gurumurthi, Ashwath
    Horwitz, Steven M.
    LEUKEMIA RESEARCH, 2025, 149
  • [46] Tumor microenvironment of adult T-cell leukemia/lymphoma
    Takeuchi, Mai
    Miyoshi, Hiroaki
    Ohshima, Koichi
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2021, 61 (04) : 202 - 209
  • [47] Genetic alterations in adult T-cell leukemia/lymphoma
    Kogure, Yasunori
    Kataoka, Keisuke
    CANCER SCIENCE, 2017, 108 (09): : 1719 - 1725
  • [48] Therapeutic Options for Adult T-Cell Leukemia/Lymphoma
    Marcais, Ambroise
    Suarez, Felipe
    Sibon, David
    Frenzel, Laurent
    Hermine, Olivier
    Bazarbachi, Ali
    CURRENT ONCOLOGY REPORTS, 2013, 15 (05) : 457 - 464
  • [49] MOGAMULIZUMAB FOR THE TREATMENT OF ADULT T-CELL LEUKEMIA/LYMPHOMA
    de Lartigue, J.
    DRUGS OF TODAY, 2012, 48 (10) : 655 - 660
  • [50] Molecular Pathology of Adult T-Cell Leukemia/Lymphoma
    Ohshima, Koichi
    ONCOLOGY, 2015, 89 : 7 - 15